The FDA is aware that Medline (MDLN) Industries has issued a letter to inform affected customers about the updated instructions for use for the certain homecare beds, the agency announced in a recall notice. “This recall involves updating instructions for using devices, and does not involve removing them from where they are used or sold,” the FDA noted.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLN:
- Medline initiated with a Buy at Tigress Financial
- How the $7B Medline (MDLN) IPO Proves Fundamentals Are Back in Vogue
- Medline price target raised to $55 from $50 at BTIG
- Top 3 Trending Stocks, According to Analysts – 1/15/2026
- 2 New IPO Stocks Hit the Market – Morgan Stanley Picks the Superior One to Buy